Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.560
+0.070 (4.70%)
Oct 19, 2026, 1:19 PM EDT - Market open
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $10.96 million as of October 19, 2026. It is the 41,376th most valuable company in the world and the 5,591st biggest in the United States.
Market Cap
10.96M
Enterprise Value
2.03M
1-Year Change
n/a
Global Rank
Country Rank
#5,591 United States
Category
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $10.96M, a decrease of -72.21%. That is a compound annual growth rate of -76.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 10.96M | -68.61% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daxor | 58.67M |
| Precision Optics Corporation | 47.40M |
| Nephros | 39.64M |
| Harvard Bioscience | 36.83M |
| Milestone Scientific | 28.97M |
| Retractable Technologies | 17.25M |
| Bionano Genomics | 14.72M |
| Femasys | 13.82M |